RadNet (NASDAQ:RDNT) operates as a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. With a mission to deliver high-quality, cost-effective solutions, RadNet’s services encompass a broad range of imaging procedures including MRI, CT scans, PET/CT, ultrasound, X-rays, and mammography, among others. RadNet is dedicated to advancing the technology and accessibility of imaging services to improve patient outcomes and healthcare efficiency. The company aims to continue expanding its network through strategic acquisitions and partnerships, enhancing its existing services, and deploying innovative imaging technologies to meet the evolving needs of the healthcare sector. With a focus on patient care, RadNet is committed to contributing positively to the communities it serves by making diagnostic imaging more accessible and affordable.